Table of Contents
Introduction
Cancer is a multifaceted disease that significantly influences nutritional status and its physiological effects on the body. In recent times, there has been an increasing concentration on nutrition's role in managing cancer. Enteral and parenteral nutrition have become essential elements of entire treatment programs.
A multitude of obstacles frequently faced by cancer patients make it difficult for them to maintain a healthy nutritional intake. Tumor-related metabolic changes, adverse effects from therapy, and malnourishment caused by cancer are some of the factors that might cause immune system impairment, weight loss, and muscular atrophy. As a result, meeting cancer patients' dietary needs has evolved into a crucial component of their overall treatment.
Cancer patients with different levels of nutritional impairment can benefit from both enteral and parenteral nutrition, which are given intravenously and through the gastrointestinal tract, respectively. Parenteral nutrition avoids the gastrointestinal tract, which may be damaged by the disease or its treatment, and delivers vital nutrients straight into the circulation. On the other hand, enteral nutrition is administered by feeding tubes or oral supplements and helps avoid infection and inflammation by preserving the gut's related lymphoid tissue, integrity, and function.
What Are the Nutritional Challenges in Cancer Patients?
Cancer has a significant impact on the nutritional state of those affected through a variety of methods. Metabolic processes can be affected by tumors, which can result in increased energy expenditure, altered nutritional use, and the diversion of vital resources for the growth of tumors. Furthermore, adverse effects from cancer therapies, including radiation, chemotherapy, and surgery, might worsen dietary inadequacies. These adverse effects, which can affect oral intake and nutritional status, may include nausea, vomiting, diarrhea, mucositis, dysphagia, and changes in taste and smell perception.
As many as 80 percent of people with certain cancers experience malnutrition, which is a common and dangerous side effect of the disease. Numerous unfavorable results are linked to it, such as a weakened immune system, lower ability to withstand cancer therapy, delayed wound healing, elevated risk of infection, poorer quality of life, and unfavorable prognosis. Therefore, it is critical to identify and treat malnutrition as soon as possible in the course of the disease to enhance outcomes from therapy and improve the general health of cancer patients.
What Is the Role of Parenteral Nutrition in Cancer Patients?
Parenteral feeding is the process of administering nutrients intravenously (IV) straight into the circulation. It is recommended for individuals with gastrointestinal disorders, obstructions, or other conditions that make it impossible for them to accept oral or enteral intake, either temporarily or permanently. Parenteral nutrition is an essential part of cancer therapy for patients suffering from severe malnutrition, intestinal blockage, bowel fistulas, severe mucositis, or other disorders that make enteral feeding difficult.
One of parenteral nutrition's main benefits is its capacity to provide vital nutrients straight to the body's cells without depending on digestion processes by avoiding the gastrointestinal system. Patients with cancer who have impaired gut function or are receiving medications that negatively impact the digestive system would especially benefit from this. Parenteral nutrition enhances overall tolerance to cancer therapy, preserves lean body mass, supports immunological function, and helps maintain or recover nutritional status by administering nutrients intravenously.
Parenteral nutrition is used to treat cancer patients. However, it has problems. Complications such as infections connected to catheter use, metabolic disorders, fluid and electrolyte imbalances, and hepatic dysfunction can arise, calling for careful observation and effective care. Furthermore, there is a continuous discussion about the best time to begin parenteral nutrition in cancer treatment; some research indicates that starting early may lead to better results, while other studies advise against using it regularly for all patients.
What Is the Role of Enteral Nutrition in Cancer Patients?
Unlike parenteral nutrition, enteral nutrition provides nutrients orally through feeding tubes straight into the gastrointestinal system. It is the recommended method of nutritional support because it protects the gut's associated lymphoid tissue, which is essential for immune defense, and maintains the integrity and function of the gut.
Enteral nutrition is recommended for cancer patients with unrepaired gastrointestinal health who cannot consume enough food orally because of functional or mechanical problems such as dysphagia, esophageal blockage, severe mucositis, or severe anorexia. Additionally, it is used as a preventative measure to reduce or prevent treatment-related malnutrition in patients receiving specific cancer therapies, such as upper gastrointestinal surgery or radiation therapy to the head and neck.
Enteral feeding can potentially lower the risk of infection problems since it preserves the integrity of the gut barrier and promotes the formation of healthy gut bacteria compared to parenteral nutrition. Additionally, enteral nourishment is linked to a decreased risk of catheter-related infections and metabolic problems, making it a safer and more economical choice in many situations.
What Are the Challenges and Considerations in Nutritional Support?
There are some difficulties and factors to take into account when using them. Although parenteral and enteral feeding are very useful in treating cancer patients, there are some difficulties and factors to consider when using them. It is important to carefully consider patient-specific characteristics such as the kind of tumor, stage, treatment plan, comorbidities, and nutritional condition to choose the best nutritional support plan. Multidisciplinary cooperation between oncologists, surgeons, nutritionists, and other medical professionals is crucial to guarantee tailored treatment and the best possible outcomes for cancer patients.
In addition, the advantages and disadvantages of enteral and parenteral nutrition should be compared while considering the patient's preferences, clinical state, prognosis, and service goals. Parenteral nutrition may be required or advantageous in certain situations, such as in patients with severe gastrointestinal dysfunction or those who cannot tolerate enteral feeding, even though enteral nutrition is recommended whenever possible.
Conclusion
Parenteral and enteral nutrition is essential for maintaining nutritional status, increasing treatment tolerance, and promoting overall quality of life in cancer patients. These techniques contribute to more effective and holistic care approaches that focus on patients' well-being throughout their cancer journey by addressing the various nutritional problems associated with cancer. Ongoing research and advancements in nutritional science continue to hone the knowledge of the best nutritional support options in oncology to increase cancer patients' outcomes and survivability.
